Cannabis Law Report

DECEMBER 7, 2021

On November 16, 2021, the Drug Enforcement Agency (DEA) issued an advance notice of proposed rulemaking , exploring whether or not to create new federal regulations governing the practice of telepharmacy. The DEA’s notice provides the industry with an opportunity to provide insight and feedback that may help shape the new regulations.

DEA 52

DEA Patients Therapy Access 52

The Cannigma

JUNE 14, 2021

For more than 50 years, if you wanted to do cannabis research in the United States, federal law said you had to get the cannabis from the University of Mississippi. The BRC is among the dozens of organizations that have received preliminary approval from the DEA to cultivate cannabis. BRC) told The Cannigma this week. Shutterstock).

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

Cannabis Law Report

OCTOBER 4, 2021

In Attorney , Federal Law , Kathryn Tucker , Oregon , Psychedelics. One of the known beneficial uses of psilocybin is as a palliative care tool for patients with advanced illness who suffer from anxiety and/or depression. Access to Psilocybin Therapy Pursuant to Right to Try Laws. Kathryn Tucker.

Therapy 52

Therapy Patients Law Clinical Trials 52

WeedAdvisor

JULY 4, 2019

Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. It could be argued that the DEA is hesitant for the sake of public safety.

DEA 111

DEA Research and Development Clinical Trials Cannabis 111

Cannabis Law Report

FEBRUARY 24, 2023

DEA extends many telemedicine flexibilities adopted during the COVID-19 PHE with appropriate safeguards WASHINGTON – Today, the Drug Enforcement Administration announced proposed permanent rules for the prescribing of controlled medications via telemedicine, expanding patient access to critical therapies beyond the scheduled end of the COVID-19 (..)

DEA 52

DEA Therapy Access Patients 52

Cannabis Law Report

SEPTEMBER 4, 2021

Circuit Court of Appeals to order the federal Drug Enforcement Authority to offer a way for terminally ill patients to try psilocybin, the active chemical in hallucinogenic mushrooms, to treat their anxiety and depression. Forty-one states have passed such laws.

Clinical Trials 109

Clinical Trials Law DEA Patients 109

Cannabis Law Report

JUNE 3, 2021

A Seattle palliative care physician has filed a lawsuit against the DEA, contesting its decision to ban psilocybin for use by terminally ill patients. Background of the Case. Read more .

DEA 98

DEA Access Clinical Trials Patients 98

Cannabis Law Report

FEBRUARY 5, 2022

Drug Enforcement Administration (DEA) this week challenging the government’s Schedule I classification of psilocybin, the main psychoactive component of psychedelic mushrooms. Seattle Doctor Files DEA Petition To Reschedule Psilocybin For Medical Use. Marijuana Moment. As part of the suit, attorneys general from eight U.S.

DEA 52

DEA Patients Marijuana 52

Cannabis Law Report

MAY 25, 2021

Marijuana Moment reports A bipartisan group of attorneys general from eight U.S. states and the District of Columbia has sided… Read More.

DEA 97

DEA Patients Marijuana 97

SpeedWeed

MAY 18, 2021

Drug Enforcement Administration (DEA) quietly made an announcement that’s expected to have a profound and long-lasting impact on cannabis research and development in the United States. For years, NIDA and the DEA have promised to open up the sourcing of federally-approved research cannabis. DEA finally relents.

DEA 52

DEA Research and Development Data Cannabis 52

Veriheal

JUNE 22, 2021

As the medical understanding of cannabinoid therapies and their actions become more advanced, hopefully, the United States federal government will be able to keep up and adjust laws pertaining to cannabis accordingly. The post DEA Increases Access to Cannabis for Research Purposes appeared first on Cannabis Central.

DEA 59

DEA Access Therapy Cannabinoids 59

Cannabis Law Report

FEBRUARY 8, 2022

A new Colorado law aimed at keeping young people from buying and reselling highly potent THC concentrate has sparked concerns from doctors who recommend medical cannabis about how the new provisions could jeopardize their ability to practice medicine. It is unknown how many doctors have decided to stop working with cannabis patients.

Patients 52

Patients Legislation Concentrates DEA 52

Cannabis Law Report

NOVEMBER 20, 2021

he Alabama State Board of Medical Examiners Thursday announced draft rules to govern how physicians can recommend medical cannabis to eligible patients. The draft rules were developed in accordance with the state’s new law on medical cannabis, which was approved earlier this year by the state Legislature and signed into law by the governor.

Patients 52

Patients DEA Dispensary Conditions 52

Veriheal

NOVEMBER 11, 2023

According to the United States Drug Enforcement Administration (DEA), Schedule One drugs are “drugs with no currently accepted medical use and a high potential for abuse.” Simply put, in the eyes of federal law, cannabis is illegal. According to Federal law, cannabis use is illegal. Is Medical Cannabis Legal? No, they can’t.

Law 62

Law Chronic Pain Conditions Legislation 62

United Patients Group

JANUARY 15, 2023

However, the DEA and FDA still consider CBD a drug regulated under the Schedule I classification. The DEA definition of a Schedule 1 substance is : Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Book a consultation today.

THC 117

THC CBD DEA Cannabinoids 117

Marijuana Lawyer Blog

JANUARY 12, 2019

Department of Justice, challenging the constitutionality of the federal law designating marijuana a Schedule I controlled substance proceeded recently to the next level with oral arguments before the U.S. Defendants are acting-Attorney General Matthew Whitaker, the acting director of the DEA and the federal government.

DEA 40

DEA Patients Epilepsy Medicine 40

Cannabis Law Report

JULY 9, 2021

The state of the law on psychedelic substances is in flux. Patients would participate in therapy sessions to prepare for the use of psychedelics, after which the substances would be administered under the guidance and supervision of trained medical professionals. have also passed “Right to Try” laws. Published Via JD Supra.

Law 105

Law Therapy Clinical Trials Research and Development 105

CannaMD

SEPTEMBER 15, 2020

Current Florida medical marijuana patient? What law legalized medical marijuana in Florida? Patients suffering from cancer, epilepsy, chronic seizures, or muscle spasms could use low-THC cannabis products recommended by a licensed doctor. How does Florida law define medical marijuana? Thinking about getting your card?

Law 126

Law Marijuana Patients Treatment 126

NORML

JANUARY 17, 2019

As the result of a lawsuit, DEA Administrative Law Judge Mary Ellen Bittner in 2007 ruled that expanding the pool of federally licensed providers would be “in the public interest.” The agency ultimately rejected her decision. Click here to send a message to your federal lawmaker and urge them to support the measure. .

Clinical Trials 229

Clinical Trials Legislation DEA Strains 229

Cannabis Law Report

JUNE 3, 2019

Plaintiffs in the case, including medical marijuana patients, told the 2nd U.S. Circuit Court of Appeals that the DEA’s refusal to reschedule cannabis damaged their health and that the federal agency should remove cannabis from Schedule 1. Federal appeals court to DEA: Reconsider marijuana’s Schedule 1 status.

DEA 59

DEA Patients Marijuana Cannabis 59

WeedAdvisor

JUNE 1, 2019

The court, citing concerns over marijuana’s Schedule I status and its impact on medical users who need it most, essentially issued an ultimatum to the DEA. Like a child who does not want to clean his or her room, the DEA simply refuses to take any major action, despite the whirlwind of reforms surrounding them on a daily basis.

DEA 55

DEA Marijuana History Cannabis 55

Cannabis Law Report

JUNE 11, 2021

Cannabis cannot be lawfully prescribed by physicians; physicians can only “recommend” its use to patients based on individual state laws that identify who qualifies as a patient for its use. This answer depends on state law. That’s about it though. Can anyone own and operate a ketamine clinic?

Law 104

Law Compliance Compliance DEA 104

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. “Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”. . Most recently the FDA awarded MMJ International Holdings ?

DEA 66

DEA Clinical Trials THC Research and Development 66

SpeedWeed

JULY 13, 2021

Governor Polis is being faced with a lawsuit over House Bill 1317, a bill that negatively affected students who were meant to benefit from the law that allows cannabis use by medical patients in public schools. . There will also be expanded tracking on purchases, and limited purchases, even for medical cannabis patients. .

Law 52

Law Patients DEA Access 52

United Patients Group

APRIL 3, 2023

A recommendation from a physician is simply permission (‘recommendation’) for the patient to use cannabis, which can be obtained in any state where medical marijuana is legal. Although both are legal under state law, there are currently 29 states with legislation allowing for medical cannabis and the District of Columbia.

DEA 52

DEA Patients Conditions Cannabis 52

Cannabis Law Report

JULY 7, 2021

Pennington, who focuses on federal appeals and regulatory issues, is co-counsel on several high-profile cases against the DEA regarding cannabis research, hemp, and psychedelics. The INCBA supports lawyers in their practice of law as they serve all aspects of the cannabis and related industries. Hemp Industries Association v.

DEA 111

DEA Hemp Cultivation Advocacy 111

The Blunt Truth

DECEMBER 15, 2023

Ohio legislators are busy writing a marijuana law. The DEA sends a letter to Georgia pharmacies. GEORGIA Earlier this fall, we noted that independent pharmacies in Georgia would begin offering low THC oil to medical marijuana patients. makes an appearance in Congress.

DEA 59

DEA Legislation Legalization Consumption 59

Cannabis Law Report

MAY 10, 2022

Activists staged a demonstration outside of the Drug Enforcement Administration (DEA) headquarters in Virginia on Monday, demanding that the agency allow terminally ill patients to access psilocybin therapy. Patients, veterans and key advocates participated in the demonstration. Marijuana Moment reports. aeidinger) May 9, 2022.

DEA 52

DEA Therapy Access Patients 52

Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). The RTT Act.

DEA 52

DEA Clinical Trials Policy Research and Development 52

Veriheal

DECEMBER 25, 2023

America has a long, complex history with drug regulation, from Sears Roebuck’s surprising sales tactics in the 1800s to the serious laws that set the stage for the modern-day war on drugs. Before 1938, over 25,000 American doctors were arraigned by the courts for writing patient prescriptions for illegal drugs.

DEA 113

DEA Legislation Law Packaging 113

Veriheal

APRIL 11, 2022

You don’t take that opium poppy and ask a patient to rub it on their lip for morphine. federal law , it has not yet been used in any commonly prescribed medicines. The company initiated the first legal transfer (as deemed by federal law) to the U.S. Drug Enforcement Agency (DEA). federal law. territories.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

JANUARY 13, 2022

In The Weeds welcomes the new year, as well as a number of new cannabis laws and policies taking effect around the country in 2022. Below is a list of state law updates to look forward to this year. 1, Louisiana’s medical cannabis program allows patients to access smokable whole-plant flower marijuana. McGuireWoods LLP.

Dispensary 52

Dispensary Law Concentrates Patients 52

MedicalJane

JUNE 29, 2018

Although this is exciting for many advocates of the plant, many patients that are suffering from ailing health conditions are left wondering what this means for them, and how exactly all of these changes will impact their healthcare options. State laws will set the guidelines for qualifying a practitioner.

Patients 83

Patients Legalization Conditions Treatment 83

United Patients Group

FEBRUARY 21, 2023

Legality In the United States, cannabis laws are changing rapidly. On a federal level, CBD is still classified as a Schedule I drug by the Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA). However, many states have passed laws allowing medical cannabis with high levels of THC to be recommended by a doctor.

THC 52

THC CBD Patients DEA 52

Cannabis Law Report

NOVEMBER 2, 2022

Drug Enforcement Administration and the legal team representing terminally ill patients petitioning for access to psilocybin-assisted therapy. In late September, the DEA denied an official petition requesting that the agency look into rescheduling psilocybin from Schedule I to Schedule II.

Microdosing 52

Microdosing DEA Therapy Access 52

The Blunt Truth

APRIL 2, 2020

DEA GUIDANCE. Scientists at the Scottsdale Research Institute have filed suit against the agency, claiming that the DEA has changed its interpretation of federal statutes and treaty obligations, without detailing how it arrived at its new view of the law. CORONAVIRUS LAWS. The cannabis industry is doing so as well.

DEA 101

DEA Hemp Packaging Recreational 101

Cannabis Law Report

DECEMBER 23, 2019

The online networks, some of which were identified based on interviews with patients and families, advertised cartridges in various brand names alongside pictures and statements about THC levels or other information clearly indicating the items for sale would be considered a controlled substance under federal law.

Vaping 59

Vaping THC DEA Supply Chain 59